These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Predictors of damage and survival in patients with Wegener's granulomatosis: analysis of 50 patients. Kamali S, Erer B, Artim-Esen B, Gul A, Ocal L, Konice M, Aral O, Inanc M. J Rheumatol; 2010 Feb; 37(2):374-8. PubMed ID: 20008921 [Abstract] [Full Text] [Related]
11. Wegener's granulomatosis in a pediatric patient. Kinn MC, Dowell M. J Okla State Med Assoc; 2003 Dec 15; 96(12):563-5; quiz 566-8. PubMed ID: 14965025 [Abstract] [Full Text] [Related]
12. Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis. Langford CA, Talar-Williams C, Sneller MC. Arthritis Rheum; 2000 Aug 15; 43(8):1836-40. PubMed ID: 10943874 [Abstract] [Full Text] [Related]
13. ANCA-associated vasculitis with renal involvement: an outcome analysis. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. Nephrol Dial Transplant; 2004 Jun 15; 19(6):1403-11. PubMed ID: 15069175 [Abstract] [Full Text] [Related]
16. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice. Stone JH, Tun W, Hellman DB. J Rheumatol; 1999 May 15; 26(5):1134-9. PubMed ID: 10332980 [Abstract] [Full Text] [Related]
17. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis]. Tervaert JW, Stegeman CA. Ned Tijdschr Geneeskd; 2003 Nov 15; 147(46):2265-7. PubMed ID: 14655291 [Abstract] [Full Text] [Related]